Trandolapril

DRUG8 trials

Sponsors

Novartis Pharma AG, Policlinico San Donato S.p.A., Abbott, AstraZeneca, University of Florida

Conditions

DiabetesHealthyHeart FailureHypertensionVentricular Dysfunction, Left

Phase 1

Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Conditions

CompletedNCT01164800

Dr. Reddy's Laboratories LimitedHealthy

Start: 2006-03-31End: 2006-05-31Updated: 2010-07-19

Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions

CompletedNCT01164787

Dr. Reddy's Laboratories LimitedHealthy

Start: 2006-03-31End: 2006-05-31Updated: 2010-07-19

Phase 2

A multi-center, randomized, placebo- and active-controlled, parallel-group, 24-week proof of concept and dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with heart failure

CompletedCTIS2023-504678-39-00

Novartis Pharma AGHeart Failure

Start: 2024-03-13End: 2024-11-08Target: 424Updated: 2024-11-08

Phase 4

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)

CompletedNCT00233532

AbbottHypertension

Start: 2004-03-31Updated: 2008-07-22

A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)

CompletedNCT00235014

AbbottDiabetes, Hypertension

Start: 1997-03-31Updated: 2008-07-15

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

CompletedNCT00391846

AstraZenecaHeart Failure, Ventricular Dysfunction, Left

Start: 2006-10-31End: 2009-01-31Updated: 2012-06-25

Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)

CompletedNCT00887510

University of FloridaHypertension

Start: 2007-05-31End: 2009-11-30Updated: 2014-06-17

Pharmacological optimization in prevention in Heart Failure: A Sex-gap? (PopS-HF Trial)

Not yet recruitingCTIS2025-520660-18-00

Policlinico San Donato S.p.A.Heart Failure

Target: 368Updated: 2025-11-17